Document Detail

Progestin modulation of estrogen-dependent marker protein synthesis in the endometrium.
MedLine Citation:
PMID:  3975654     Owner:  NLM     Status:  MEDLINE    
While it is well known that progestins have significant effects on estrogen-dependent processes in the uterus, very little is known about the molecular details of these effects. To understand these processes we have developed an immunocytochemical staining technique to help clarify the progestin regulation of estrogen receptor (ER), and we have also studied the effects of progestins on estrogen-dependent specific protein synthesis and secretion in the immature rat uterus. The immunocytochemical method for identifying estrogen receptor in tissue sections uses biotinylated monoclonal antibody to the estrogen receptor protein and shows a largely nuclear localization of the receptor protein in the rat uterine endometrium and myometrium. This method can be used to explore changes in the intercellular and intracellular localization of the uterine ER during progestin action. In an effort to correlate these changes with specific biological responses in the uterus we have been studying the effects of the administration of estrogens and progestins in vivo on the synthesis of specific proteins in uterine target cells in vitro. We previously reported that one-dimensional SDS-PAGE analysis of labeled secreted uterine proteins and cellular proteins extracted from the luminal epithelium and from the stroma plus myometrial fractions of the uterus revealed that estradiol-17 beta preferentially stimulated the synthesis of 110,000, 74,000, and 66,000 dalton secreted proteins, and 180,000 and 110,000 dalton epithelial proteins. We found that while progestins administered alone in vivo did not have any stimulatory effect on the synthesis of these secreted or cellular uterine proteins, concomitant administration of either progesterone or megestrol acetate and estradiol in vivo substantially reduced the estrogen-stimulated increase in labeling of the 110,000, 74,000, and 66,000 dalton secreted uterine proteins in vitro. In animals first primed with the progestin prior to combined estrogen/progestin treatment, the progestins were even more effective antagonists of estrogen. In addition, progestins alone given 24 hours after estradiol substantially inhibited the estrogen-stimulated synthesis of these proteins. These results suggest that progestins can both modulate the initial level of estrogen stimulation of synthesis of specific proteins and selectively terminate their synthesis, by affecting the continued transcription of their estrogen-regulated genes, altering the processing, half-life, or translation of their mRNAs, or by modulating the translation or the posttranslational processing of the nascent peptide chains.
E R DeSombre; P C Kuivanen
Related Documents :
25031084 - Conserved structure and domain organisation amongst bacterial slc26 transporters.
23402764 - Dual ph- and temperature-responsive microparticles for protein delivery to ischemic tis...
24854094 - Tumor-specific delivery of sirna using supramolecular assembly of hyaluronic acid nanop...
24276494 - Physicochemical properties of seeds of capparis species growing wild in turkey.
22435364 - Cardiac protein changes in ischemic and dilated cardiomyopathy: a proteomic study of hu...
24510614 - Site-specific protein labeling with snap-tags.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Seminars in oncology     Volume:  12     ISSN:  0093-7754     ISO Abbreviation:  Semin. Oncol.     Publication Date:  1985 Mar 
Date Detail:
Created Date:  1985-04-17     Completed Date:  1985-04-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0420432     Medline TA:  Semin Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  6-11     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Endometrium / metabolism*
Estrogens / pharmacology*
Gene Expression Regulation / drug effects
Megestrol / analogs & derivatives,  pharmacology
Megestrol Acetate
Models, Biological
Progestins / pharmacology*
Protein Biosynthesis*
Receptors, Estrogen / analysis
Uterus / analysis
Reg. No./Substance:
0/Estrogens; 0/Progestins; 0/Receptors, Estrogen; 3562-63-8/Megestrol; 51154-23-5/Megestrol Acetate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estro...
Next Document:  Vindesine, etoposide (VP-16), and prednisolone (VEP) in relapsed patients with grade II non-Hodgkin'...